Monobenzone

Table of contents

  • Brand Names
  • Chemistry
  • Pharmacologic Category
  • Mechanism of Action
  • Therapeutic Use
  • Pregnancy and Lactation Implications
  • Contraindications
  • Warnings and Precautions
  • Adverse Reactions
  • Genes that may be involved
  • Drug Interactions
  • Dosage

Brand Names

Europe

Poland: Monobenzone.

North America

Canada: Benoquin.

Drug combinations

Chemistry

Monobenzone: C~13~H~12~O~2~. Mw: 200.23. (1) Phenol, 4-(phenylmethoxy)-; (2) p-(Benzyloxy)phenol. CAS-103-16-2.

Pharmacologic Category

Depigmenting Agents. Topical Skin Product. (ATC-Code: D11AX13).

Mechanism of action

Increases excretion of melanin from melanocytes. Causes melanocyte destruction and permanent depigmentation.

Therapeutic use

Final depigmentation in extensive vitiligo.

Pregnancy and lactiation implications

Animal reproduction studies not conducted. Excretion in breast milk unknown (use caution).

Unlabeled use

Contraindications

Hypersensitivity to monobenzone or any component of the formulation. Use as cosmetic skin bleach. Use as hydroquinone substitute.

Warnings and precautions

Photosensitivity. For external use only. Not recommended for use in freckling, hyperpigmentation caused by photosensitization, melasma, hyperpigmentation resulting from skin inflammation, cafe-au-lait spots, pigmented nevi, or malignant melanoma.

Information

Legal

Legal Notice
Privacy Policy
Cookie Policy

Contact

Phone: +34-981-780505
Email: genomicmedicine@wagem.org
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart